Kalvista Interest Income from 2010 to 2026

KALV Stock

USD 15.61 0.04 0.26%

Kalvista Pharmaceuticals Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income is likely to outpace its year average in 2026. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-04-30

Previous Quarter

2 M

Current Value

1.8 M

Quarterly Volatility

563.1 K

Covid

Interest Hikes

Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 0.0 or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 46.95, Dividend Yield of 0.0 or Days Sales Outstanding of 273. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.

Build AI portfolio with Kalvista Stock

Check out the analysis of Kalvista Pharmaceuticals Correlation against competitors.

For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.

The evolution of Interest Income for Kalvista Pharmaceuticals provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Kalvista Pharmaceuticals compares to historical norms and industry peers.

Latest Kalvista Pharmaceuticals' Interest Income Growth Pattern

Below is the plot of the Interest Income of Kalvista Pharmaceuticals over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Kalvista Pharmaceuticals' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Kalvista Interest Income Regression Statistics

	Arithmetic Mean	1,326,249
	Geometric Mean	380,616
	Coefficient Of Variation	128.11
	Mean Deviation	1,168,440
	Median	1,090,000
	Standard Deviation	1,699,122
	Sample Variance	2.9T
	Range	6.4M
	R-Value	0.69
	Mean Square Error	1.6T
	R-Squared	0.47
	Significance	0
	Slope	230,921
	Total Sum of Squares	46.2T

Kalvista Interest Income History

	2026	2.1 M
	2024	6.4 M
	2023	3.9 M
	2022	2.2 M
	2021	1.1 M
	2020	903 K
	2019	1.8 M

Other Fundumenentals of Kalvista Pharmaceuticals

Net Interest Income

Kalvista Pharmaceuticals Interest Income component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Long Term Debt Total	Capital Surpluse	Property Plant Equipment	Net Tangible Assets	Net Receivables	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.93	0.47	-0.49	-0.81	0.78	0.31	1.0	-0.44	0.84	0.38	0.72	0.66	0.58	0.77	0.81	-0.11	0.21	0.88	0.85	0.51
Total Stockholder Equity	0.93		0.51	-0.36	-0.6	0.72	-0.06	0.93	-0.54	0.73	0.34	0.75	0.76	0.67	0.86	0.78	-0.12	0.17	0.95	0.82	0.39
Current Deferred Revenue	0.47	0.51		-0.66	-0.31	0.4	-0.06	0.47	-0.8	0.46	-0.47	0.22	0.35	0.53	0.55	0.5	0.4	-0.65	0.41	0.47	0.38
Net Debt	-0.49	-0.36	-0.66		0.47	-0.35	-0.35	-0.5	0.43	-0.66	0.12	-0.33	-0.28	-0.34	-0.38	-0.31	-0.16	0.28	-0.38	-0.66	-0.77
Retained Earnings	-0.81	-0.6	-0.31	0.47		-0.84	-0.66	-0.81	0.15	-0.87	-0.36	-0.57	-0.3	-0.28	-0.33	-0.69	0.12	-0.24	-0.52	-0.62	-0.64
Accounts Payable	0.78	0.72	0.4	-0.35	-0.84		0.24	0.77	-0.31	0.82	0.29	0.61	0.34	0.39	0.38	0.63	-0.1	0.15	0.67	0.64	0.58
Total Liab	0.31	-0.06	-0.06	-0.35	-0.66	0.24		0.31	0.21	0.39	0.19	0.01	-0.18	-0.16	-0.15	0.21	0.04	0.18	-0.08	0.15	0.36
Total Current Assets	1.0	0.93	0.47	-0.5	-0.81	0.77	0.31		-0.44	0.83	0.38	0.71	0.66	0.58	0.77	0.8	-0.11	0.21	0.88	0.85	0.51
Short Term Debt	-0.44	-0.54	-0.8	0.43	0.15	-0.31	0.21	-0.44		-0.41	0.21	-0.31	-0.46	-0.67	-0.56	-0.55	-0.3	0.45	-0.39	-0.34	-0.1
Common Stock	0.84	0.73	0.46	-0.66	-0.87	0.82	0.39	0.83	-0.41		0.37	0.77	0.43	0.45	0.45	0.69	-0.13	0.17	0.64	0.77	0.76
Long Term Debt	0.38	0.34	-0.47	0.12	-0.36	0.29	0.19	0.38	0.21	0.37		0.62	0.33	0.2	0.22	0.37	-0.6	0.96	0.4	0.4	0.26
Long Term Debt Total	0.72	0.75	0.22	-0.33	-0.57	0.61	0.01	0.71	-0.31	0.77	0.62		0.52	0.61	0.57	0.71	-0.32	0.47	0.66	0.69	0.48
Capital Surpluse	0.66	0.76	0.35	-0.28	-0.3	0.34	-0.18	0.66	-0.46	0.43	0.33	0.52		0.79	0.9	0.71	-0.14	0.18	0.77	0.61	0.18
Property Plant Equipment	0.58	0.67	0.53	-0.34	-0.28	0.39	-0.16	0.58	-0.67	0.45	0.2	0.61	0.79		0.77	0.81	0.2	0.03	0.58	0.47	0.13
Net Tangible Assets	0.77	0.86	0.55	-0.38	-0.33	0.38	-0.15	0.77	-0.56	0.45	0.22	0.57	0.9	0.77		0.74	-0.08	0.07	0.86	0.74	0.23
Net Receivables	0.81	0.78	0.5	-0.31	-0.69	0.63	0.21	0.8	-0.55	0.69	0.37	0.71	0.71	0.81	0.74		0.0	0.19	0.64	0.59	0.3
Deferred Long Term Liab	-0.11	-0.12	0.4	-0.16	0.12	-0.1	0.04	-0.11	-0.3	-0.13	-0.6	-0.32	-0.14	0.2	-0.08	0.0		-0.64	-0.23	-0.22	-0.17
Short Long Term Debt	0.21	0.17	-0.65	0.28	-0.24	0.15	0.18	0.21	0.45	0.17	0.96	0.47	0.18	0.03	0.07	0.19	-0.64		0.25	0.24	0.14
Net Invested Capital	0.88	0.95	0.41	-0.38	-0.52	0.67	-0.08	0.88	-0.39	0.64	0.4	0.66	0.77	0.58	0.86	0.64	-0.23	0.25		0.9	0.48
Net Working Capital	0.85	0.82	0.47	-0.66	-0.62	0.64	0.15	0.85	-0.34	0.77	0.4	0.69	0.61	0.47	0.74	0.59	-0.22	0.24	0.9		0.78
Capital Stock	0.51	0.39	0.38	-0.77	-0.64	0.58	0.36	0.51	-0.1	0.76	0.26	0.48	0.18	0.13	0.23	0.3	-0.17	0.14	0.48	0.78

Click cells to compare fundamentals

About Kalvista Pharmaceuticals Financial Statements

Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	1.2 M	2.1 M
Net Interest Income	747.5 K	1.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Kalvista Stock Analysis

When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Kalvista Interest Income from 2010 to 2026

Latest Kalvista Pharmaceuticals' Interest Income Growth Pattern

Kalvista Interest Income Regression Statistics

Kalvista Interest Income History

Other Fundumenentals of Kalvista Pharmaceuticals

Kalvista Pharmaceuticals Interest Income component correlations

About Kalvista Pharmaceuticals Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Kalvista Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY